Brief: Acucort Gets Approval To Start Bioequivalence Study For The US

AcuCort AB

23/01/2019 11:26

Jan 23 (Reuters) - AcuCort AB  ACUC.TE :
    * ACUCORT OBTAINS REGULATORY APPROVAL TO START
BIOEQUIVALENCE
STUDY FOR THE US
    * ANNOUNCES THAT CZECH STATE INSTITUTE FOR DRUG CONTROL,
SUKL HAS
APPROVED COMPANY'S APPLICATION TO CONDUCT FIRST OF TWO
BIOEQUIVALENCE STUDIES
    * ARE PLANNED TO BE BASIS FOR A REGISTRATION APPLICATION FOR
COMPANY'S INNOVATIVE ALLERGY DRUG DEXA ODF IN UNITED STATES.

Source text for Eikon:  ID:nWkrLqTp 
Further company coverage:  ACUC.TE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 587720920;))